| Question 1: Voriconazole has become the new standard of care in the treatment of invasive aspergillosis, which may occur in immunocompromised patients, including allogeneic BMT, other hematologic cancers, and solid ________. | |||
|
|
| Question 2: Voriconazole (VFEND, ________) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. | |||
|
|
| Question 3: This is based on the results of a large, randomized study in which voriconazole proved superior to ________ with 53% complete or partial response, compared with 32% for amphotericin B. | |||
|
|
| Question 4: These are generally seen in patients who are immunocompromised, and include invasive ________, invasive aspergillosis, and certain emerging fungal infections. | |||
|
|
|
|
Wikis
Quiz
Search
